期刊文献+

微波促进固相合成胰高血糖素样肽-1类似物及其降血糖活性 被引量:1

Solid phase synthesis of glucagon-like peptide-1 analogues under microwave irradiation and their hypoglycemic activities
下载PDF
导出
摘要 目的:提高胰高血糖素样肽-1(GLP-1)对二肽激肽酶(DPPⅣ)的稳定性。方法:以Rink Amide-MBHA树脂为载体,采用Fmoc/t-Bu正交保护固相合成策略,运用微波照射促进合成GLP-1类似物,最后经过反相制备高效液相色谱纯化得到目标多肽纯品。结果:所合成的GLP-1及其类似物的相对分子质量和纯度均经过电喷雾质谱和高效液相色谱确证。降血糖活性研究结果显示,改造后的GLP-1类似物有很好的降血糖活性且作用时间较长。结论:修饰后的GLP-1类似物在保留降糖活性的同时延长了作用时间,这为开发新型抗糖尿病药物提供了基础。 Aim: To improve the stability of glucagon-like peptide-1 (GLP-1) to the degradation by dipeptidyl peptidase IV ( DPP IV). Methods: A rapid and efficient microwave irradiation solid phase synthesis method was implemented in the preparation of the GLP-1 analogues on Rink Amide-MBHA resin by an Fmoc/t-Bu orthogonal protection strategy. The crude peptides were purified by preparative RP-HPLC. Results: The molecular weight and purity of GLP-1 analogues have been confirmed by the electrospray mass spectrometry analysis and the HPLC method. The study of the biological activity showed GLP-1 analogues decreased the blood glucose prominently. Conclusion: The modified GLP-1 analogues have prolonged glucose-lowering activity, which might be on the pipeline of novel antidiabetic candidates.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2008年第4期306-311,共6页 Journal of China Pharmaceutical University
关键词 胰高血糖素样肽-1 固相合成 微波辐射 降血糖活性 glucagon-like peptide-1 solid phase synthesis microwave irradiation hypoglycemic activity
  • 相关文献

参考文献16

  • 1Knudsen LB. Glucagon-like Peptide-1 :the basis of a new class of treatment for type 2 diabetes [ J ]. J Med Chem, 2004,47 ( 17 ) : 4 128-4 134.
  • 2Kieffer TJ, Habener JF. The glucagon-like peptides [ J ]. Endocr Rev,1999,20(6) :876 -913.
  • 3Runge S, Wulff BS, Madsen K, et al. Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity[ J]. Br JPharmacol,2003, 138(5) :787 2794.
  • 4Vilsboll T, Krarup T, Madsbad S, et al. No reactive hypoglycaemia in Type 2 diabetie patients after subcutaneous administration of GLP-1 and intravenous glucose [ J]. Diabet Med, 2001,18 (2) :144 -149.
  • 5Hui HX,Zhao XN, Perfetti P. Structure and function studies of glucagon-like peptide-1 ( GLP-1) : the designing of a novel pharmacolagical agent for the treatment of diabetes [ J]. Diabetes Metab Res Rev,2005,21 (4) :313 - 331.
  • 6Egan JM,Bulotta A,Hui HX,et al. GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells [ J ]. Diabetes Metab Res Rev.2003,19 (2) : 115 - 123.
  • 7Holz GG,Kiihyteiber WM, Habener JF. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-Iike peptide-1 (7-37) [J]. Nature, 1993,361 (6 410 ) :362 - 365.
  • 8Mentlein R, Gallwitz B, Schmidt WE. Dipeptidyl-pepfidase Ⅳ hydrolyses gastric inhibitory polypepfide, glueagon-like pepfide-1 (7-36) amide ,pepfide hislidine methlonine and is responsible for their degradation in human serum [ J ]. Eur J Biochem, 1993,214 (3) :829 -835.
  • 9Kaiser E, Colescott RL, Bossinger CD,et al. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides [ J ]. Anal Biochem, 1970,34 (2) :595 - 598.
  • 10Krehnak V, Vagner J, Lebl M. Noninvasive continuous monitoring of solid phase peptide synthesis by acid-base indicator[ J]. Int J Peptide Protein Res,1988,32(2) :415 -416.

同被引文献502

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部